These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9651150)

  • 1. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
    John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
    J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
    John CS; Gulden ME; Vilner BJ; Bowen WD
    Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
    John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
    Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
    John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
    Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
    Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
    Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
    John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
    Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.
    John CS; Lim BB; Geyer BC; Vilner BJ; Bowen WD
    Bioconjug Chem; 1997; 8(3):304-9. PubMed ID: 9177835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
    John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
    Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Investigation of a [
    Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
    Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
    Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
    Nguyen VH; Kassiou M; Johnston GA; Christie MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
    Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
    J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
    Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
    J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
    Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
    Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents.
    de Costa B; Radesca L; Dominguez C; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jun; 35(12):2221-30. PubMed ID: 1319493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines.
    Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
    Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM
    Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.